CreativeOne Wealth’s Alaunos Therapeutics TCRT Stock Holding History

CreativeOne Wealth’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-99	Closed	-$2K	–	671
2023 Q3	$2K	Hold	99	–	–	﹤0.01%	567
2023 Q2	$8K	Buy	+99	New	+$8.01K	﹤0.01%	827

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCA

Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

CreativeOne Wealth's TCRT Position: Q4 2023 in Review

CreativeOne Wealth sold out of Alaunos Therapeutics (TCRT) in Q4 2023, closing a stake of 99 shares — an estimated $2K sold.

CreativeOne Wealth first reported a position in TCRT in Q2 2023 and held it in 2 quarters. The position peaked at $8K in Q2 2023. 82 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.

CreativeOne Wealth reported no remaining Alaunos Therapeutics position as of Q4 2023 after selling out during the quarter.
CreativeOne Wealth sold 99 Alaunos Therapeutics shares in Q4 2023, an estimated $2K.
CreativeOne Wealth first reported a position in Alaunos Therapeutics in Q2 2023 and held it in 2 quarters.
CreativeOne Wealth's Alaunos Therapeutics position peaked at $8K in Q2 2023.
82 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.

Based on CreativeOne Wealth's 13F filing for Q4 2023, filed 9 Feb 2024.